AIM Therapeutics Inc. Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Toronto ON Canada (2005)
Status: Defunct (2017)

Organization Overview

First Clinical Trial
2012
NCT01501942
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Ningbo Rongan Biological Pharmaceutical Co. Ltd | Ningbo Rongan Biological Pharmaceutical Co. Ltd. | Ningbo Rongan Biological Pharmaceutical Co., Ltd.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 10
  • # of Trial APIs: 9